Childhood Acute Lymphoblastic Leukaemia: Follow-Up

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

December 30, 2020

Study Completion Date

January 20, 2021

Conditions
Precursor Cell Lymphoblastic Leukemia-LymphomaRecurrence
Interventions
OTHER

Mode of relapse/SMN detection

Mode of relapse/SMN detection: whether the relapse/SMN was diagnosed because of symptoms of leukaemia or diagnosed at a routine visit in the outpatient clinic.

Trial Locations (5)

101

The National University Hospital of Iceland, Reykjavik

8200

Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus N

9038

Department of Childhood Oncology, University Hospital Tromsø, Tromsø

20521

Department of Paediatrics and Adolescent Medicine, Turku University Hospital, Turku

171 76

Department of Paediatric Oncology, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT03545659 - Childhood Acute Lymphoblastic Leukaemia: Follow-Up | Biotech Hunter | Biotech Hunter